The economics of delayed diagnosis in the United States:

The EveryLife Foundation for Rare Diseases has published a new study on the economic implications of delayed diagnosis of rare diseases.

Timely diagnosis of rare diseases is key for patients to be able to access potentially life-saving treatment and improved quality of life.

Beyond the health benefits, however, delayed diagnoses also come with greater costs for health systems.

(orphanews International 2023.09.29)